Bone Graft Substitutes Market, By Type (Allograft (Machined Allograft and Demineralized Bone Matrix), Bone Graft Substitute (Bone Morphogenic Proteins (BMP) and Synthetic Bone Grafts), and Cell-based Matrices), By Application (Spinal Fusion, Trauma, Joint Reconstruction, Dental Bone Grafting, and Craniomaxillofacial), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030

The market for bone graft alternatives was valued at US$ 2.78 billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 4.1% to reach US$ 4.19 billion by 2030. The markets for bone substitutes worldwide are divided into five regions: North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America is expected to generate the largest revenue share in 2018 due in part to increased healthcare spending, increased consumer knowledge of commercially accessible goods, and sophisticated healthcare infrastructure. In the upcoming years, it is anticipated that the Asia Pacific region will see profitable expansion. Increased medical tourism and supportive government measures are to blame for the surge. Strict regulations, however, make adoption difficult in several of the nations.